Dr. Philip Kern, M.D.
Claim this profileUniversity of Kentucky
Studies Prediabetes
Studies Impaired Glucose Tolerance
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Philip Kern, M.D. is currently running
Mirabegron + Tadalafil
for Prediabetes
This trial is testing whether mirabegron, a drug that helps the body use sugar better, can improve blood sugar levels in obese, insulin-resistant people who are prediabetic. Mirabegron is a β3-adrenergic receptor agonist initially approved for treating overactive bladder, with potential benefits for metabolic diseases. The study also looks at whether adding tadalafil, another drug, can make mirabegron work even better. Participants will be treated for several months.
Recruiting2 awards Phase 42 criteria
Mirabegron
for Prediabetes
Mirabegron (Myrbetriq®, Astellas) is a highly specific and well-tolerated ß3 agonist marketed for overactive bladder. This trial will assess the effects of mirabegron on glucose tolerance and adipose tissue in prediabetic patients
Recruiting0 awards Phase 23 criteria
More about Philip Kern, M.D.
Clinical Trial Related4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Philip Kern, M.D. has experience with
- Mirabegron
- Placebo
- Tadalafil
Breakdown of trials Philip Kern, M.D. has run
Impaired Glucose Tolerance
Incretin Hormones in Polycystic Ovary Syndrome
Glanzmann thrombasthenia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Philip Kern, M.D. specialize in?
Philip Kern, M.D. focuses on Prediabetes and Impaired Glucose Tolerance. In particular, much of their work with Prediabetes has involved treating patients, or patients who are undergoing treatment.
Is Philip Kern, M.D. currently recruiting for clinical trials?
Yes, Philip Kern, M.D. is currently recruiting for 2 clinical trials in Lexington Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Philip Kern, M.D. has studied deeply?
Yes, Philip Kern, M.D. has studied treatments such as Mirabegron, Placebo, Tadalafil.
What is the best way to schedule an appointment with Philip Kern, M.D.?
Apply for one of the trials that Philip Kern, M.D. is conducting.
What is the office address of Philip Kern, M.D.?
The office of Philip Kern, M.D. is located at: University of Kentucky, Lexington, Kentucky 40536 United States. This is the address for their practice at the University of Kentucky.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.